27 Best Stocks to Own in 2017 | Kiplinger

Skip advert Amid a dense fog of uncertainty, an aging bull will have to find its foothold in 2017. rarely has the way forward been so obscured by the cloudy policies of a fresh political regimen, adenine well as by questions about economic growth, monetary policy and the animal spirits—or lack thereof—of America ’ randomness corporate chieftains. With change afoot, along with an basically voice economy, you ’ ll do best by favoring stocks over bonds, zeroing in on companies with solid long-run emergence trends and rising dividends, and by finding sectors that will prosper with Donald Trump in the White House.

Here are 27 stock picks that Kiplinger ‘s invest editors Daren Fonda and Anne Kates Smith, ampere well as columnist James K. Glassman, see offering promise in the class ahead .

NEW STOCK PICKS FOR 2018: 18 Best Stock to Buy for 2018

Stocks are in alphabetic regulate. share prices and early data are as of December 8, 2016 .Skip advert

Alphabet

Skip advert

  • Symbol: GOOGL
  • 52-week high: $839.00
  • 52-week low: $672.66
  • Annual revenues: $85.5 billion
  • Projected 2017 earnings growth: 20%

The market value of Alphabet is $ 552 billion, so it ’ s hard to fathom it getting much bigger. But the owner of Google, YouTube and other technical school businesses hasn ’ triiodothyronine peaked. recent intersection launches include the Pixel smartphone and Google Home ( a virtual personal assistant ). Add those products to Alphabet ’ s early businesses—including thriving sales of on-line ads, apps and cloud-based services—and you get a fast that analysts believe will generate 20 % profit growth in 2017. At 27 times estimated earnings, the stock doesn ’ metric ton front expensive .

SEE LAST YEAR’S STOCK PICKS: 26 Best Stocks for 2016

Skip advert

Amazon.com

Skip advert

  • Symbol: AMZN
  • 52-week high: $847.21
  • 52-week low: $474.00
  • Annual revenues: $128.0 billion
  • Projected 2017 earnings growth: 93%

The giant of on-line retail besides has a solid position in obscure computer science, and is moving aggressively into video content and artificial intelligence ( not to mention drone rescue ). Amazon.com took a shoot in October because of disappoint earnings, but this well-run company continues to have its eyes on the long term. Value Line sees revenues rising 19.5 % annually over the next five years .

 

Skip advert

CME Group

Skip advert

  • Symbol: CME
  • 52-week high: $122.74
  • 52-week low: $81.87
  • Annual revenues: $3.5 billion
  • Projected 2017 earnings growth: 10%
  • CME Group owns the Chicago Mercantile Exchange and other trading venues where speculators bet on everything from the price of pork bellies to the future level of Standard & Poor’s 500-stock index. CME has expanded by merging with other exchanges and providing more services to traders.

CME pays a regular dividend of 60 cents a contribution and will likely pay a especial dividend at year-end. That could lift the total payout to $ 5.67 a share in 2017, estimates Bank of America Merrill Lynch, giving the stock a hefty 5.1 % move over .

 

Skip advert

CPI Aerostructures

Skip advert

  • Symbol: CVU
  • 52-week high: $9.74
  • 52-week low: $4.35
  • Annual revenues: $89 million
  • Projected 2017 earnings growth: 17%
  • CPI Aerostructures makes structural parts, such as wing assemblies and fuel panels, for commercial and military aircraft. The firm recorded a huge loss in 2014, but it has recovered and, according to Dan Abramowitz, a small-cap stock specialist based in Rockville, Md., says it enjoys “a large and growing backlog” of orders. With a market cap of $69 million, CPI is the smallest company on our list, so expect a wild ride. But the potential reward looks like it’s worth the risk.

Skip advert

Crown Castle International

Skip advert

  • Symbol: CCI
  • 52-week high: $102.82
  • 52-week low: $75.71
  • Annual revenues: $3.8 billion
  • Projected 2017 earnings growth: 6.5%

A real estate investment trust, Crown Castle leases space on closely 40,000 cell-phone towers to wireless carriers, such as AT & T and Verizon. Income is climbing as customers consume more data on mobile devices. cable television providers such as Charter Com­munications and Comcast besides plan to roll out wireless service in 2017, boosting demand for outer space on cell-phone towers. As a REIT, Crown Castle must shell out at least 90 % of its taxable income to investors. Paying $ 3.80 per share, the store yields 4.4 % .Skip advert

Henry Schein

Skip advert

  • Symbol: HSIC
  • 52-week high: $183.00
  • 52-week low: $142.64
  • Annual revenues: $11.3 billion
  • Projected 2017 earnings growth: 10%
  • Henry Schein is an 84-year-old company that distributes health supplies to physicians, dentists and veterinarians. A mid-cap stock, Schein is not a superfast grower, but it has a rock-solid niche, with earnings expected to rise at a good clip. Of note: Schein has been in the portfolio of T. Rowe Price New Horizons (PRNHX) since 1996.

Skip advert

Kraft Heinz

Skip advert

  • Symbol: KHC
  • 52-week high: $90.54
  • 52-week low: $68.18
  • Annual revenues: $26.8 billion
  • Projected 2017 earnings growth: 19%

Warren Buffett, who turned 86 in August, is however America ’ second greatest exist investor. He frequently buys entire companies for Berkshire Hathaway, the ship’s company he runs. A few years ago, he purchased about one-fourth of Kraft Heinz, the universe ’ mho fifth-largest food caller, with such august brands as Jell-O, Oscar Mayer and Velveeta. On a P/E footing, the sprout international relations and security network ’ thymine cheap. It is unlikely to soar, but it offers a 2.9 % dividend yield and could add ballast to any portfolio .

TAKE THE QUIZ: How Well Do You Know Warren Buffett?

Skip advert

Medpace Holdings

Skip advert

  • Symbol: MEDP
  • 52-week high: $38.94
  • 52-week low: $26.51
  • Annual revenues: $410 million
  • Projected 2017 earnings growth: 6.5%

Running clinical trials for biotechnology firms, Medpace handles everything from the design of a research study to its execution. Sales should climb at a 13 % annual yard through 2020, and the tauten should be able to maintain industry-leading net income margins above 30 %, says UBS. Medpace would face setbacks if drugmakers were to reduce spend for clinical trials. But the humble fast, which went public last August at $ 23 a partake, takes a “ unique and full-service approach ” to the business, says UBS. It rates the stock a “ buy ” and expects the price to hit $ 35 over the following class .Skip advert

Micron Technology

Skip advert

  • Symbol: MU
  • 52-week high: $20.99
  • 52-week low: $9.31
  • Annual revenues: $12.4 billion
  • Projected fiscal year 2018 earnings growth: 35%
  • Micron Technology, an Idaho-based semiconductor maker, has been struggling, but some analysts see profits rising sharply over the next year or two. Micron has found favor with Parnassus Endeavor (PARWX), one of the top-performing large-company funds over the past five years. It’s the fund’s top holding and one of the few stocks it added in 2016. But it’s a contrarian play for sure.

 

Skip advert

Palo Alto Networks

Skip advert

  • Symbol: PANW
  • 52-week high: $189.95
  • 52-week low: $111.09
  • Annual revenues: $1.5 billion
  • Projected 2017 earnings growth: 58%*
  • Palo Alto Networks sells sophisticated hardware and software to protect networks against cyberattacks. Sales are rising steadily as the firm expands its product lineup and signs up more customers for subscriptions to its cloud-based software, creating revenue streams that should last for years. Although growth is slowing, analysts still see revenues increasing a healthy 28%, to $2.3 billion, in the fiscal year that ends in January 2018.

* Based on operate earningsSkip advert

Raytheon

Skip advert

  • Symbol: RTN
  • 52-week high: $152.58
  • 52-week low: $115.73
  • Annual revenues: $24.2 billion
  • Projected 2017 earnings growth: 5.9%

After stagnating for years, U.S. military spending is likely to pick up once Donald Trump takes position. That should boost sales for Raytheon, which makes military products—from Patriot missiles to electronic war systems. The tauten ’ s rate reserve hit $ 35.8 billion in the third quarter of 2016, up by $ 2.2 billion from a year earlier. Foreign sales, about one-third of the total, are besides rising. Bank of America Merrill Lynch says Raytheon will be a “ beneficiary of a global arms race. ” It rates the stock a “ buy ” and sees it hitting $ 160 over the future 12 months .

 

Skip advert

Regeneron Pharmaceuticals

Skip advert

  • Symbol: REGN
  • 52-week high: $563.79
  • 52-week low: $325.35
  • Annual revenues: $4.7 billion
  • Projected 2017 earnings growth: 5.2%

Biotech fast Regeneron makes one of the top-selling drugs to prevent eye diseases in the aged. That product, Eylea, accounts for about two-thirds of the firm ’ s sales, estimated at $ 5 billion in 2016. Regeneron ’ s batting order besides includes Praluent, a drug to combat high cholesterol that ’ mho being tested as a treatment to prevent second heart attacks. The company may soon win regulative approval for a new drug for arthritic arthritis, and it has several early promising drugs in late-stage studies .Skip advert

Salesforce.com

Skip advert

  • Symbol: CRM
  • 52-week high: $84.48
  • 52-week low: $52.60
  • Annual revenues: $7.9 billion
  • Projected fiscal year 2018 earnings growth: 109%
  • Salesforce.com is a rapidly expanding company that sells web-based software that helps companies manage relationships with their customers. It’s broadening its product lineup and pushing into areas such as data analytics and digital marketing, as well as making acquisitions to fuel its expansion, such as a recent deal to buy e-commerce company Demandware for $2.8 billion.

Terry Tillman, a technology analyst with Raymond James, sees revenues rising by 25 % in the fiscal year that ends January 31, 2017, and by 21 % for the postdate class .

 

Skip advert

Sanofi

Skip advert

  • Symbol: SNY
  • 52-week high: $44.50
  • 52-week low: $36.81
  • Annual revenues: $38.3 billion
  • Projected 2017 earnings growth: -0.3%

few companies receive circus tent rankings for both seasonableness and safety from the Value Line Investment Survey. Promoted to that exalted status in late October was Sanofi , the Paris-based godhead of pharmaceuticals, with an vehemence on diabetes medicines. Sanofi ’ s stock yields a hefty 4.31 %, an indication that it may be undervalued. The 43-year-old company is a major name in drugs for diabetes, cancer and rare diseases. It besides produces vaccines for illnesses such as typhoid and dengue, and it owns biotechnology firm Genzyme. Sanofi besides has besides boosted its presence in over-the-counter consumer products ( such as painkillers and cold treatments ) by acquiring the consumer weapon of german drug elephantine Boehringer Ingelheim .Skip advert

Simon Property Group

Skip advert

  • Symbol: SPG
  • 52-week high: $229.10
  • 52-week low: $174.91
  • Annual revenues: $5.4 billion
  • Projected 2017 earnings growth: 9.3%

Like Crown Castle International, Simon Property Group is a real estate investment trust, with regional malls and mercantile establishment shopping centers around the world. Simon ’ randomness stock has been bland since the depart of 2015 as exuberance for REITs has waned ( though it ’ south placid the largest by market hood ). Consider that an opportunity. Simon Property Group is the top hold of Ivy LaSalle Global Risk-Managed Real Estate ( IVRAX ), an excellent REIT fund, and yields an attractive 3.6 % .

 

Skip advert

Starbucks

Skip advert

  • Symbol: SBUX
  • 52-week high: $61.79
  • 52-week low: $50.84
  • Annual revenues: $21.3 billion
  • Projected 2017 earnings growth: 13%
  • Starbucks, which needs no introduction, has suffered of late, sinking 2.6% over the past year. That makes it even more attractive especially with no serious competitors on the horizon, a gorgeous balance sheet, and earnings that Value Line predicts will rise 16% annually over the next five years. You’ll find the coffee-shop chain in the holdings of Fidelity Contrafund (FCNTX), run by the estimable Will Danoff for a quarter-century.

 

Skip advert

Take-Two Interactive Software

Skip advert

  • Symbol: TTWO
  • 52-week high: $50.56
  • 52-week low: $31.36
  • Annual revenues: $1.5 billion
  • Projected fiscal year 2018 earnings growth: 20%

You may not have heard of Take-Two Interactive, but you ’ ve probably hear of at least one of the games it makes : Grand Theft Auto. Take-Two ’ sulfur revenues and profits have been bouncing up and down recently with the popularity of its products, but analysts see brisk earnings gains for the year ahead. Flush with cash, the firm could be a coup d’etat target. With a market capitalization of $ 4.3 billion, Take-Two has about $ 1.5 billion in cash and short-run investments and merely $ 512 million in debt. It ’ s a top hold of aggressive growth fund World Innovators ( WAGTX ) .

 

Skip advert

Health Care Stocks

Skip advert Consider a sector that is typically regarded as defensive but recently has been anything but. Health care stocks were pummeled by members of Congress on both sides of the political aisle in 2016, as Republicans threatened to repeal the Affordable Care Act and Democrats waged war on drug prices. But drug and biotechnology stocks rebounded strongly after Trump ’ s victory. Mike Bailey, conductor of research for FBB Capital Partners, a money-management firm in Bethesda, Md., likes Alexion Pharmaceuticals ( ALXN ), which specializes in treatments for rare diseases ; checkup device maker CR Bard ( BCR ) ; and insurer UnitedHealth Group ( UNH ) .

 

Skip advert

technology Stocks

Skip advert technology stocks should do well if there ’ s even a puff of economic slowdown and investors shift their focus to companies that can grow in good times or bad. S & P 500 technical school companies are expected to log earnings growth of 12 % in 2017, the highest of any sector save energy and materials, both clawing their means back from the verge. FBB ’ south Bailey recommends Microsoft ( MSFT ), which has exposure to cloud calculation, and Visa ( V ), which operates the universe ’ mho largest electronic-payments net. A promote in infrastructure spending is already reflected in the share prices of many of the machinery companies and other firms you ’ five hundred expect to benefit .

SEE LAST YEAR’S STOCK PICKS: 26 Best Stocks for 2016

Skip advert

fiscal Stocks

Skip advert When rates are rising, fiscal stocks deserve a look—particularly now that regulations will probable be scrutinized and possibly lightened. beyond banks, such as J.P. Morgan ( JPM ) and PNC Financial Services Group ( PNC ), consider companies with an endow kicker, says Bailey. He likes TD Ameritrade ( AMTD ), which should see a rise in concern income once short-run rates rise. It is besides expanding aggressively, recently agreeing to buy equal Scottrade for $ 4 billion .

 

Skip advert

consumer Stocks

Skip advert Companies that cater to consumers will benefit from any tax cuts that leave more money for outgo on non-necessities. Restaurants, hotels and specially high-end retailers should prosper now that the terror of tax increases on the affluent has been pushed digression, says Savita Subramanian, a strategist at Bank of America Merrill Lynch. Consider Marriott International ( MAR ) and retailer Signet Jewelers ( SIG ) .

 

source : https://enrolldetroit.org
Category : Social

Trả lời

Email của bạn sẽ không được hiển thị công khai.